BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 3275401)

  • 1. [Production of monoclonal antibodies against rabies virus].
    Akacem O; Benmansour A; Benhassine M
    Arch Inst Pasteur Alger; 1986; 55():269-74. PubMed ID: 3275401
    [No Abstract]   [Full Text] [Related]  

  • 2. [Production of monoclonal antibodies against a wild strain of rabies virus].
    Akacem O; Benmansour A; Coulon P; Brahimi M; Benhassine M
    Arch Inst Pasteur Alger; 1992; 58():283-90. PubMed ID: 1309144
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Specificity of monoclonal antibodies obtained with the Paster PV rabies virus strain].
    Libeau G; Lafon M; Rollin PE
    Rev Elev Med Vet Pays Trop; 1984; 37(4):383-94. PubMed ID: 6400350
    [No Abstract]   [Full Text] [Related]  

  • 4. Preparation and identification of anti-rabies virus monoclonal antibodies.
    Wang WJ; Li X; Wang LH; Shan H; Cao L; Yu PC; Tang Q; Liang GD
    Virol Sin; 2012 Jun; 27(3):172-8. PubMed ID: 22684471
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of human monoclonal antibodies to rabies.
    Dorfman N; Dietzschold B; Kajiyama W; Fu ZF; Koprowski H; Notkins AL
    Hybridoma; 1994 Oct; 13(5):397-402. PubMed ID: 7860096
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A rabies-specific human monoclonal antibody that protects mice against lethal rabies.
    Enssle K; Kurrle R; Köhler R; Müller H; Kanzy EJ; Hilfenhaus J; Seiler FR
    Hybridoma; 1991 Oct; 10(5):547-56. PubMed ID: 1804770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and characterization of a human monoclonal antibody that potently neutralizes a broad panel of rabies virus isolates.
    Sloan SE; Hanlon C; Weldon W; Niezgoda M; Blanton J; Self J; Rowley KJ; Mandell RB; Babcock GJ; Thomas WD; Rupprecht CE; Ambrosino DM
    Vaccine; 2007 Apr; 25(15):2800-10. PubMed ID: 17240489
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of an anti-rabies human monoclonal antibody combination with human polyclonal anti-rabies immune globulin.
    Goudsmit J; Marissen WE; Weldon WC; Niezgoda M; Hanlon CA; Rice AB; Kruif Jd; Dietzschold B; Bakker AB; Rupprecht CE
    J Infect Dis; 2006 Mar; 193(6):796-801. PubMed ID: 16479514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The isolation and characteristics of hybridomas producing monoclonal antibodies to the structural proteins of the Vnukovo-32 strain of the rabies virus].
    Gribencha SV; Vasilenko OV; Furalev VA; Kliushnik SIu; Kuz'mitskaia TM; Sveshinkov PG; Barinskiĭ IF
    Vopr Virusol; 1991; 36(4):318-21. PubMed ID: 1796588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a cocktail of recombinant-expressed human rabies virus-neutralizing monoclonal antibodies for postexposure prophylaxis of rabies.
    Prosniak M; Faber M; Hanlon CA; Rupprecht CE; Hooper DC; Dietzschold B
    J Infect Dis; 2003 Jul; 188(1):53-6. PubMed ID: 12825170
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel monoclonal antibodies that bind to wild and fixed rabies virus strains.
    Zanluca C; Aires LR; Mueller PP; Santos VV; Carrieri ML; Pinto AR; Zanetti CR
    J Virol Methods; 2011 Jul; 175(1):66-73. PubMed ID: 21536074
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Development of allogenic hybridomas for production of monoclonal antibodies against oral polio vaccine strains.
    Gupta CK; Sokhey J; Gupta RK; Singh H
    Vaccine; 1991 Nov; 9(11):853-4. PubMed ID: 1661979
    [No Abstract]   [Full Text] [Related]  

  • 13. Novel human monoclonal antibody combination effectively neutralizing natural rabies virus variants and individual in vitro escape mutants.
    Bakker AB; Marissen WE; Kramer RA; Rice AB; Weldon WC; Niezgoda M; Hanlon CA; Thijsse S; Backus HH; de Kruif J; Dietzschold B; Rupprecht CE; Goudsmit J
    J Virol; 2005 Jul; 79(14):9062-8. PubMed ID: 15994800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of rabies virus strains used for vaccine production by means of monoclonal antibodies.
    Sureau P; Rollin P; Lafon M
    Dev Biol Stand; 1984; 57():227-31. PubMed ID: 6084613
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antigenic variants of rabies virus in isolates from eastern, central and northern Canada.
    Webster WA; Casey GA; Charlton KM; Wiktor TJ
    Can J Comp Med; 1985 Apr; 49(2):186-8. PubMed ID: 3893660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antigenic analysis of rabies and Mokola virus from Zimbabwe using monoclonal antibodies.
    Wiktor TJ; Macfarlan RI; Foggin CM; Koprowski H
    Dev Biol Stand; 1984; 57():199-211. PubMed ID: 6526138
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding properties of monoclonal antibodies to rabies virus.
    Cusi MG; Valensin PE; Tollis M; Bracci L; Petreni S; Soldani P
    Microbiologica; 1991 Jul; 14(3):205-11. PubMed ID: 1921740
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [In vitro seroneutralization of rabies virus in Leighton tubes, evaluated by immunofluorescence inhibition].
    Seroka D; Labuńska E
    Med Dosw Mikrobiol; 1981; 33(1):67-72. PubMed ID: 7024687
    [No Abstract]   [Full Text] [Related]  

  • 19. [Use of monoclonal antibodies in virology].
    Lashkevich VA
    Vopr Virusol; 1983; 28(6):648-54. PubMed ID: 6322450
    [No Abstract]   [Full Text] [Related]  

  • 20. Immunoperoxidase cell surface localization of rabies virus antigen in tissue cultures at a low viral multiplicity.
    Revilla-Monsalve C; Hernández-Jáuregui P; Silva-Lemoine E
    Arch Invest Med (Mex); 1985; 16(1):11-7. PubMed ID: 3893349
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.